Gene Expression Profiling Associated with the Progression of Classic Kaposi's Sarcoma

Although Kaposi's sarcoma (KS) gene expression profile is closer to lymphatic (LEC) rather than blood vascular endothelial cells (BEC), uncertainty still surrounds the cellular origin of KS. To follow KS progression from early to late (nodular) stage, and characterize the molecular fingerprinting associated with each stage, gene arrays were used to compare gene expression profile of 9 skin samples of classic KS (4 Early, 2 Mixed, and 3 Nodular CKS samples) to 4 normal samples. Results for selected genes were validated by Real-time (RT) PCR and immunohistochemistry. Genes regulating immune and defense responses, angiogenesis, apoptosis and proliferation were differentially expressed in different KS stages compared to normal skin. Hierarchical clustering separated normal skin from KS with a clear gradient from early to nodular KS lesions. The gene expression level of endothelium markers, metalloproteinases, angiogenic factors and chemokines, gradually increased from normal through all KS stages. The expression of LEC genes highly increased from early to nodular KS. In the initiation phase we noticed a higher expression of growth factors, as compared to progressive stages. LEC and BEC markers co-exist in “KS expression signature”, although the LEC signature prevailed. Our results also show a complex environment of inflammatory cells and chemokines during KS evolution. A pathogenic hypothesis where cellular hyperproliferation is driven by local expression of chemokines and growth factors without clonal expansion of cells is suggested.

[1]  D. Ganem.  KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. , 2010, The Journal of clinical investigation.

[2]  Paul Kellam,et al.  KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. , 2010, Genes & development.

[3]  P. Chaudhary,et al.  Kaposi's sarcoma associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a , 2009, Oncogene.

[4]  Young Bong Choi,et al.  Autocrine and Paracrine Promotion of Cell Survival and Virus Replication by Human Herpesvirus 8 Chemokines , 2008, Journal of Virology.

[5]  B. Chandran,et al.  Kaposi's Sarcoma-Associated Herpesvirus Induces Sustained Levels of Vascular Endothelial Growth Factors A and C Early during In Vitro Infection of Human Microvascular Dermal Endothelial Cells: Biological Implications , 2007, Journal of Virology.

[6]  J. Gu,et al.  Immunoglobulin G expression in carcinomas and cancer cell lines , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  C. Lebbé,et al.  Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma. , 2007, Journal of the National Cancer Institute.

[8]  S. Amatschek,et al.  Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment. , 2007, Blood.

[9]  C. Boshoff,et al.  Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. , 2007, Cancer research.

[10]  Shou-Jiang Gao,et al.  Kaposi's Sarcoma-Associated Herpesvirus Infection Promotes Invasion of Primary Human Umbilical Vein Endothelial Cells by Inducing Matrix Metalloproteinases , 2007, Journal of Virology.

[11]  Shou-Jiang Gao,et al.  Kaposi's Sarcoma-Associated Herpesvirus Promotes Angiogenesis by Inducing Angiopoietin-2 Expression via AP-1 and Ets1 , 2007, Journal of Virology.

[12]  S. Thurner,et al.  Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro. , 2007, Physiological genomics.

[13]  L. Pantanowitz,et al.  Matrix metalloproteinases in the progression and regression of Kaposi’s sarcoma , 2006, Journal of cutaneous pathology.

[14]  G. Schettini,et al.  CXC Receptor and Chemokine Expression in Human Meningioma , 2006, Annals of the New York Academy of Sciences.

[15]  J. Ott,et al.  Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. , 2006, The Journal of investigative dermatology.

[16]  N. Dupin,et al.  Looking for the target cell of Kaposi's sarcoma-associated herpesvirus. , 2006, The Journal of investigative dermatology.

[17]  H. Augustin,et al.  Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation , 2006, Nature Medicine.

[18]  A. Gessain,et al.  Spindle cells and their role in Kaposi's sarcoma. , 2005, The international journal of biochemistry & cell biology.

[19]  S. Rockson,et al.  The lymphatic biology of Kaposi's sarcoma. , 2005, Lymphatic research and biology.

[20]  Thomas Hartmann,et al.  Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. , 2004, Cancer cell.

[21]  Elizabeth Brazeau,et al.  Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. , 2004, Virology.

[22]  Jay W. Shin,et al.  Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus , 2004, Nature Genetics.

[23]  S. Henderson,et al.  Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma , 2004, Nature Genetics.

[24]  Zhong-ying Liu,et al.  Alpha-chemokine-mediated signal transduction in human Kaposi's sarcoma spindle cells. , 2004, Biochimica et biophysica acta.

[25]  B. Chandran,et al.  Host Gene Induction and Transcriptional Reprogramming in Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV-8)-Infected Endothelial, Fibroblast, and B Cells , 2004, Cancer Research.

[26]  衛藤 剛.  Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma : possible in vivo regulation via induction of proteases , 2004 .

[27]  S. Pittaluga,et al.  Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis. , 2003, Blood.

[28]  L. Xerri,et al.  A multicentre study of percentage change in venous leg ulcer area as a prognostic index of healing at 24 weeks , 2003, The British journal of dermatology.

[29]  C. Boshoff,et al.  Aids-related malignancies , 2002, Nature Reviews Cancer.

[30]  Richard G. Jenner,et al.  The molecular pathology of Kaposi's sarcoma-associated herpesvirus. , 2002, Biochimica et biophysica acta.

[31]  G. Getz,et al.  DNA microarrays identification of primary and secondary target genes regulated by p53 , 2001, Oncogene.

[32]  H. Dvorak,et al.  Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. , 2000, The American journal of pathology.

[33]  R. Gallo.  The Enigmas of Kaposi's Sarcoma , 1998, Science.

[34]  B. Nathwani,et al.  Evidence for multiclonality in multicentric Kaposi's sarcoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[36]  E. Berti,et al.  Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[37]  J. Regezi,et al.  Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells. , 1993, The American journal of pathology.